Barclays upgraded shares of ConvaTec Group (OTCMKTS:CNVVY – Free Report) to a strong-buy rating in a research report released on Wednesday, Zacks.com reports.
Separately, UBS Group raised ConvaTec Group to a strong-buy rating in a research report on Wednesday, June 26th. Three equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of Buy and an average price target of $295.00.
Check Out Our Latest Analysis on ConvaTec Group
ConvaTec Group Trading Down 2.5 %
ConvaTec Group Cuts Dividend
The company also recently disclosed a dividend, which will be paid on Monday, October 21st. Stockholders of record on Friday, August 23rd will be issued a dividend of $0.0584 per share. The ex-dividend date is Friday, August 23rd.
ConvaTec Group Company Profile
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.
Further Reading
- Five stocks we like better than ConvaTec Group
- ESG Stocks, What Investors Should Know
- Chevron Stock Dips as Earnings Miss Highlights Merger Uncertainty
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- DraftKings Shares Fall After EPS Beat, Lower EBITDA Guidance
- Canadian Penny Stocks: Can They Make You Rich?
- Investors Flock to Auto Retail Stock as It Hits New Highs
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.